Adial Pharmaceuticals Inc

NASDAQ:ADIL  
0.38
0.00 (-1.28%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Adial Pharmaceuticals Inc Stock, NASDAQ:ADIL

1180 Seminole Trail, Suite 495, Charlottesville, Virginia 22901
United States of America
Phone: +1.434.422.9800
Number of Employees: 18

Description

Adial Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on the treatment of alcohol use disorder. Its lead product is AD04, a selective serotonin-3 antagonist. The company was founded by Bankole A. Johnson in November 2010 and is headquartered in Charlottesville, VA.